Paul McBarron
2014
In 2014, Paul McBarron earned a total compensation of $346.8K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 53% decrease compared to previous year.
Compensation breakdown
| Salary | $324,442 |
|---|---|
| Other | $22,315 |
| Total | $346,757 |
McBarron received $324.4K in salary, accounting for 94% of the total pay in 2014.
McBarron also received $22.3K in other compensation.
Rankings
In 2014, Paul McBarron's compensation ranked 11,393rd out of 13,032 executives tracked by ExecPay. In other words, McBarron earned more than 12.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,393 out of 13,032 | 13th |
Division Manufacturing | 4,359 out of 4,965 | 12th |
Major group Chemicals And Allied Products | 1,515 out of 1,690 | 10th |
Industry group Drugs | 1,227 out of 1,369 | 10th |
Industry Pharmaceutical Preparations | 938 out of 1,042 | 10th |
Source: SEC filing on April 11, 2016.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2014.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020